Highlights
- Vincere makes new medicines to treat age-related diseases including Parkinson’s and Kidney disease.
- Our work is backed by top agencies such as the National Institutes of Health and the Michael J Fox Foundation with over $2.7 million in grant funding.
- Expert investors include Daewoong Pharma, HanAll Biopharma, Healthspan Capital, QuadraScope and others.
- Using our advanced AI/ML tools, our stellar team has made over 1000 molecules protected by over 20 global patents.
- The first molecule will reach human trials and potential pharma partnerships within 18 months. Additional molecules/indications provide more shots on goal.
